141 related articles for article (PubMed ID: 10644721)
1. Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193.
Morris SK; Baird CL; Lindsley JE
J Biol Chem; 2000 Jan; 275(4):2613-8. PubMed ID: 10644721
[TBL] [Abstract][Full Text] [Related]
2. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
3. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
[TBL] [Abstract][Full Text] [Related]
4. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
Roca J; Ishida R; Berger JM; Andoh T; Wang JC
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1781-5. PubMed ID: 8127881
[TBL] [Abstract][Full Text] [Related]
5. Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP.
Morris SK; Lindsley JE
J Biol Chem; 1999 Oct; 274(43):30690-6. PubMed ID: 10521457
[TBL] [Abstract][Full Text] [Related]
6. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II drives DNA transport by hydrolyzing one ATP.
Baird CL; Harkins TT; Morris SK; Lindsley JE
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13685-90. PubMed ID: 10570133
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human DNA topoisomerase II alpha with DNA: quantification by surface plasmon resonance.
Renodon-Cornière A; Jensen LH; Nitiss JL; Jensen PB; Sehested M
Biochemistry; 2002 Nov; 41(45):13395-402. PubMed ID: 12416984
[TBL] [Abstract][Full Text] [Related]
9. Pre-steady-state analysis of ATP hydrolysis by Saccharomyces cerevisiae DNA topoisomerase II. 2. Kinetic mechanism for the sequential hydrolysis of two ATP.
Harkins TT; Lewis TJ; Lindsley JE
Biochemistry; 1998 May; 37(20):7299-312. PubMed ID: 9585544
[TBL] [Abstract][Full Text] [Related]
10. ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization.
Hu T; Sage H; Hsieh TS
J Biol Chem; 2002 Feb; 277(8):5944-51. PubMed ID: 11850431
[TBL] [Abstract][Full Text] [Related]
11. Pre-steady-state analysis of ATP hydrolysis by Saccharomyces cerevisiae DNA topoisomerase II. 1. A DNA-dependent burst in ATP hydrolysis.
Harkins TT; Lindsley JE
Biochemistry; 1998 May; 37(20):7292-8. PubMed ID: 9585543
[TBL] [Abstract][Full Text] [Related]
12. The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) release.
Baird CL; Gordon MS; Andrenyak DM; Marecek JF; Lindsley JE
J Biol Chem; 2001 Jul; 276(30):27893-8. PubMed ID: 11353771
[TBL] [Abstract][Full Text] [Related]
13. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
Kwon Y; Shin BS; Chung IK
J Biol Chem; 2000 Jun; 275(24):18503-10. PubMed ID: 10764786
[TBL] [Abstract][Full Text] [Related]
14. Stability of the topoisomerase II closed clamp conformation may influence DNA-stimulated ATP hydrolysis.
Vaughn J; Huang S; Wessel I; Sorensen TK; Hsieh T; Jensen LH; Jensen PB; Sehested M; Nitiss JL
J Biol Chem; 2005 Mar; 280(12):11920-9. PubMed ID: 15647268
[TBL] [Abstract][Full Text] [Related]
15. On the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II.
Lindsley JE; Wang JC
J Biol Chem; 1993 Apr; 268(11):8096-104. PubMed ID: 8385137
[TBL] [Abstract][Full Text] [Related]
16. Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II.
Olland S; Wang JC
J Biol Chem; 1999 Jul; 274(31):21688-94. PubMed ID: 10419479
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines.
Jensen LH; Nitiss KC; Rose A; Dong J; Zhou J; Hu T; Osheroff N; Jensen PB; Sehested M; Nitiss JL
J Biol Chem; 2000 Jan; 275(3):2137-46. PubMed ID: 10636919
[TBL] [Abstract][Full Text] [Related]
18. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.
Classen S; Olland S; Berger JM
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10629-34. PubMed ID: 12963818
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.
Ishida R; Hamatake M; Wasserman RA; Nitiss JL; Wang JC; Andoh T
Cancer Res; 1995 Jun; 55(11):2299-303. PubMed ID: 7757979
[TBL] [Abstract][Full Text] [Related]
20. A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles.
Skouboe C; Bjergbaek L; Oestergaard VH; Larsen MK; Knudsen BR; Andersen AH
J Biol Chem; 2003 Feb; 278(8):5768-74. PubMed ID: 12480934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
